Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
American Journal of Obstetrics and Gynecology|September 1, 1995
Ultrasonographic bone characteristics during normal pregnancy: longitudinal and cross-sectional evaluationM Gambacciani, A Spinetti, R Gallo, et al.
Climacteric : the Journal of the International Menopause Society|October 29, 2010
Clinical and metabolic effects of drospirenone-estradiol in menopausal women: a prospective studyM Gambacciani, G Rosano, B Cappagli, et al.
Neuroendocrinology|February 1, 1989
Pulsatile gonadotropin-releasing hormone release from the human mediobasal hypothalamus in vitro: opiate receptor-mediated suppressionD D Rasmussen, M Gambacciani, W Swartz, et al.
Maturitas|December 1, 1992
Effects of continuous and cyclic nasal calcitonin administration in ovariectomized womenP Fioretti, M Gambacciani, F Taponeco, et al.
Climacteric : the Journal of the International Menopause Society|April 29, 2017
Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases?N Biglia, A Cagnacci, M Gambacciani, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|October 17, 2008
A prospective, randomized, controlled study comparing Gynemesh, a synthetic mesh, and Pelvicol, a biologic graft, in the surgical treatment of recurrent cystoceleF Natale, C La Penna, A Padoa, et al.
Neuroendocrinology|February 1, 1988
Chronic bromocriptine administration restores luteinizing hormone response to naloxone in postmenopausal womenG B Melis, A Cagnacci, M Gambacciani, et al.
Climacteric : the Journal of the International Menopause Society|March 26, 2002
Climacteric modifications in body weight and fat tissue distributionM Gambacciani, M Ciaponi, B Cappagli, et al.
Fertility and Sterility|September 1, 1989
Reduction in the size of prolactin-producing pituitary tumor after Cabergoline administrationG B Melis, M Gambacciani, A M Paoletti, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1988
Restoration of luteinizing hormone response to naloxone in postmenopausal women by chronic administration of the antidopaminergic drug veraliprideG B Melis, A Cagnacci, M Gambacciani, et al.
Pageof 12